decisionhealth Newsletters, Answer Books - 2008 Issue 5 (May)
Appendix E - National Coverage Determinations Manual / BLOOD
Subscribe or sign in to view the full article.
Article Overview
This page presents a National Coverage Determination from the Medicare National Coverage Determinations Manual focused on blood-derived products used in chronic non-healing wounds. It is relevant for clinicians, coders, compliance staff, and reimbursement professionals who need to understand the broad coverage status, the scope of the determination, and related references to Medicare policy and trial coverage. The article provides general coverage context, noncovered indication categories, and administrative notes tied to the effective date and review history.
Why This Topic Matters
Coverage status for wound-care products affects claim submission, medical necessity review, and compliance workflows. Understanding the scope of this determination helps users distinguish national policy from local discretion and clinical trial-related coverage.
Article Sections
-
General
Introduces the subject area and provides background on the category of blood-derived products addressed by the determination. The section also outlines the clinical context for chronic non-healing wounds.
-
Nationally Covered Indications
States the covered-indications status for the determination. This section is brief and serves as a policy status marker.
-
Nationally Noncovered Indications
Describes the noncovered indication categories addressed by the determination. It focuses on the types of treatments and the broader basis for their noncoverage at a policy level.
-
Other
Includes additional coverage notes, including local discretion and clinical trial-related policy language. The section also references administrative and manual guidance context.
What You Will Learn
- The coverage scope of a Medicare National Coverage Determination for blood-derived wound treatments
- How the article distinguishes covered, noncovered, and other policy categories
- What general administrative and trial-related policy references accompany the determination
- Which broad product categories and wound-care contexts are addressed
Who Should Read This
- Medical coders
- Compliance professionals
- Revenue cycle staff
- Clinicians involved in wound care
- Healthcare administrators
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com